Blood recirculating devices, which include ventricular assist devices and prosthetic heart valves, are necessary for some patients suffering from end-stage heart failure and valvular diseases. However, disturbed flow patterns in these devices cause shear-induced platelet activation and aggregation. Thromboembolic complications resulting from this platelet behavior necessitates lifelong anticoagulant therapy for patients implanted with such devices. In addition, blood recirculating device manufacturers mostly test and optimize their products for hemolysis, which occurs at shear stresses ten-fold higher than required for platelet activation. The relative paucity of optimization for flow-induced thrombogenicity is further exacerbated by the fact that there are few predictive shear-induced platelet activation models.
- Bioengineering Division
Evaluation of Platelet Activation Models With Dynamic Shear Stress In Vitro Experiments
- Views Icon Views
- Share Icon Share
- Search Site
Sheriff, J, Xenos, M, Soares, JS, Jesty, J, & Bluestein, D. "Evaluation of Platelet Activation Models With Dynamic Shear Stress In Vitro Experiments." Proceedings of the ASME 2012 Summer Bioengineering Conference. ASME 2012 Summer Bioengineering Conference, Parts A and B. Fajardo, Puerto Rico, USA. June 20–23, 2012. pp. 883-884. ASME. https://doi.org/10.1115/SBC2012-80134
Download citation file: